Xieon Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 26-09-2024
- Paid Up Capital ₹ 1.30 Cr
as on 26-09-2024
- Company Age 17 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.00 Cr
as on 26-09-2024
- Satisfied Charges ₹ 0.20 M
as on 26-09-2024
- Revenue -6.53%
(FY 2023)
- Profit 67.59%
(FY 2023)
- Ebitda 184.82%
(FY 2023)
- Net Worth 29.81%
(FY 2023)
- Total Assets 13.11%
(FY 2023)
About Xieon Life Sciences
The Corporate was formerly known as Xieon Lifesiences Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.30 Cr.
The company currently has active open charges totaling ₹3.00 Cr. The company has closed loans amounting to ₹0.20 M, as per Ministry of Corporate Affairs (MCA) records.
Yogesh Singla, Ankur Goyal, and Ashok Bambha serve as directors at the Company.
- CIN/LLPIN
U51101DL2007PTC159289
- Company No.
159289
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Feb 2007
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
North West Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Xieon Life Sciences Private Limited offer?
Xieon Life Sciences Private Limited offers a wide range of products and services, including Physiotherapy & Rehab Aids, Fracture Aid, Nutraceuticals & Dietary Supplements, Nutritional Supplements, Wheel Chairs, Crutches and Walker, Walking Aids, Anti Infective Drugs & Medicines, Antibiotic Tablets, Capsule & Syrup, Cosmetics, Hair & Beauty Products, Body Lotions.
Who are the key members and board of directors at Xieon Life Sciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Yogesh Singla  | Managing Director | 14-Feb-2007 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ankur Goyal | Director | 14-Feb-2007 | Current |
| Ashok Bambha | Director | 01-May-2010 | Current |
Financial Performance of Xieon Life Sciences.
Xieon Life Sciences Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 6.53% decrease. The company also saw a substantial improvement in profitability, with a 67.59% increase in profit. The company's net worth Soared by an impressive increase of 29.81%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Xieon Life Sciences?
In 2023, Xieon Life Sciences had a public holding of 35.38%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 11 Mar 2015 | ₹3.00 Cr | Open |
Punjab National Bank Creation Date: 03 Nov 2008 | ₹0.20 M | Satisfied |
How Many Employees Work at Xieon Life Sciences?
Unlock and access historical data on people associated with Xieon Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Xieon Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Xieon Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
